Granulocyte Chemotactic Protein 2 (CXCL6) Bovine Recombinant
Granulocyte Chemotactic Protein 2 (CXCL6) Bovine Recombinant produced in E.Coli is a non-glycosylated polypeptide chain containing 76 amino acids and having a molecular mass of approximately 8.0kDa.
GCP2 is purified by proprietary chromatographic techniques.
Escherichia Coli.
Sterile Filtered White lyophilized (freeze-dried) powder.
Granulocyte Chemotactic Protein 2 (CXCL6) Human Recombinant
Key Biological Properties: CXCL6 is chemotactic for neutrophil granulocytes and has strong antibacterial activity against both Gram-positive and Gram-negative bacteria .
Expression Patterns and Tissue Distribution: CXCL6 is expressed in various tissues, including bronchial epithelial cells, spleen, olfactory zone of nasal mucosa, cartilage tissue, and islet of Langerhans beta cells . It is also found in the right lobe of the liver, cervix, endothelial cells of lymphatic vessels, and trachea .
Primary Biological Functions: CXCL6 plays a crucial role in recruiting neutrophils to sites of inflammation, thereby contributing to non-specific immunity . It also has angiogenic properties and promotes tissue repair .
Role in Immune Responses and Pathogen Recognition: CXCL6 is involved in the immune response by attracting neutrophils to infection sites, enhancing the body’s ability to fight off pathogens .
Mechanisms with Other Molecules and Cells: CXCL6 exerts its effects by binding to chemokine receptors CXCR1 and CXCR2 . This interaction triggers downstream signaling pathways that lead to chemotaxis and activation of neutrophils .
Binding Partners and Downstream Signaling Cascades: The binding of CXCL6 to CXCR1 and CXCR2 activates G protein-coupled receptor signaling pathways, leading to various cellular responses, including chemotaxis and activation of immune cells .
Regulatory Mechanisms Controlling Expression and Activity: The expression of CXCL6 is regulated by various factors, including cancer-related genes and interleukin family members . These factors can promote the abnormal secretion of CXCL6, which in turn affects tumor growth and metastasis .
Transcriptional Regulation and Post-Translational Modifications: Specific transcription factors and kinases, such as RELA, NFKB1, LCK, and PAK2, play a role in the transcriptional regulation of CXCL6 . Post-translational modifications, such as phosphorylation, may also influence its activity .
Biomedical Research: CXCL6 is a potential therapeutic target for inflammation and cancer due to its role in recruiting neutrophils and promoting angiogenesis .
Diagnostic Tools and Therapeutic Strategies: Elevated levels of CXCL6 can serve as biomarkers for diseases such as idiopathic pulmonary fibrosis and various cancers . Therapeutic strategies targeting CXCL6 and its receptors are being explored for their potential to modulate immune responses and inhibit tumor progression .